Exodus Point Capital Management, LP Arcutis Biotherapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 1,113,582 shares of ARQT stock, worth $9.71 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,113,582
Previous 222,222
401.11%
Holding current value
$9.71 Million
Previous $2.2 Million
370.3%
% of portfolio
0.07%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding ARQT
# of Institutions
193Shares Held
128MCall Options Held
5.43MPut Options Held
257K-
Jennison Associates LLC11.6MShares$101 Million0.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY10MShares$87.2 Million3.89% of portfolio
-
Rubric Capital Management LP New York, NY9.82MShares$85.6 Million2.7% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$76.6 Million4.82% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$75.2 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $525M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...